Vascular Cognitive Impairment (Highly Investigational)

Resumen para el Paciente

¿Está esto autorizado por FDA para este uso?

Not FDA-cleared for vascular cognitive impairment / vascular dementia. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, June 2004). Use here is Tier C investigational.

¿Qué evidencia existe?

Tier C (highly investigational). No controlled trials. Evidence-based first-line management is aggressive vascular risk factor control (blood pressure, LDL cholesterol, diabetes, smoking cessation), anti-platelet therapy after non-cardioembolic stroke, cognitive rehabilitation, and exercise. Cholinesterase inhibitors (donepezil, galantamine) have modest evidence in vascular cognitive impairment but are not FDA-approved for that indication.

Riesgos principales

• Bleeding from each bite site for 6 to 10 hours after the leech detaches
• Iron-deficiency anemia from cumulative blood loss across multiple sessions
• Aeromonas hydrophila wound infection from leech gut bacteria (uncommon outside reconstructive surgery, but possible)
• Allergic reaction to leech saliva (rare; ranges from local itching to anaphylaxis)
• Permanent Y-shaped bite-mark scars or hyperpigmentation at attachment sites
• Local pain, bruising, swelling, or itching for 1 to 3 days after each session
• Hemodynamic compromise — blood volume reduction may worsen cerebral perfusion in patients with severe stenosis
• Drug interactions if the patient is on antiplatelet or anticoagulant therapy (most should be)

Quién no debería considerar esto

• Patients on antiplatelet or anticoagulant therapy after stroke (this is standard secondary prevention)
• Patients with poorly controlled hypertension, diabetes, or lipids (these need optimization first)
• Patients with severe carotid stenosis without prior vascular workup
• Anyone on blood thinners such as warfarin, apixaban, rivaroxaban, dabigatran, heparin, or daily aspirin used for medical reasons
• People with hemophilia or any other inherited bleeding disorder
• Patients with severe anemia (hemoglobin under 10 g/dL)
• People with an active infection at the planned application site

Qué preguntar a su clínico

• Are all my vascular risk factors (BP, lipids, diabetes, smoking) optimally controlled?
• Am I on appropriate antiplatelet or anticoagulant therapy for stroke prevention?
• Has carotid imaging been done to exclude treatable stenosis?
• How will leech therapy interact with my blood-thinner medications?
• What is the published evidence base for leeches in vascular dementia?
• How will cognitive function be objectively measured before and after?

Cuándo buscar atención urgente

• Bleeding from a bite site that soaks through more than one dressing per hour
• Bleeding that continues more than 24 hours after the leech detached
• Spreading redness, warmth, swelling, pus, or red streaks around any bite site
• Fever over 38.0 C / 100.4 F, chills, or feeling suddenly unwell after a session
• Hives, facial or tongue swelling, throat tightness, or any difficulty breathing
• Sudden weakness, dizziness, fast heart rate, or fainting (possible severe blood loss)
• Sudden weakness, speech change, vision loss, facial droop, or severe headache (possible stroke or TIA)
• Sudden confusion, severe drop in cognitive function, or new fall